Nymox Pharmaceutical (NYMX)

Add to Watchlists
Create an Alert
4.19 +0.00  +0.00% NASDAQ Apr 23, 16:59 Delayed 2m USD

Nymox Pharmaceutical Price to Book Value

View 4,000+ financial data types
Browse...
View Full Chart

Nymox Pharmaceutical Price to Book Value Chart

Export Data
Save Image
Print Image

Nymox Pharmaceutical Historical Price to Book Value Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 29, 2017 20119.57
Dec. 28, 2017 20363.44
Dec. 27, 2017 20058.60
Dec. 26, 2017 20119.57
Dec. 22, 2017 20180.54
Dec. 21, 2017 20607.32
Dec. 20, 2017 20912.16
Dec. 19, 2017 20790.22
Dec. 18, 2017 21095.07
Dec. 15, 2017 21521.84
Dec. 14, 2017 21399.91
Dec. 13, 2017 22131.53
Dec. 12, 2017 20668.29
Dec. 11, 2017 20851.19
Dec. 8, 2017 20729.25
Dec. 7, 2017 20790.22
Dec. 6, 2017 21643.78
Dec. 5, 2017 22680.24
Dec. 4, 2017 22741.21
Dec. 1, 2017 22497.34
Nov. 30, 2017 22985.09
Nov. 29, 2017 23167.99
Nov. 28, 2017 23716.71
Nov. 27, 2017 22985.09
Nov. 24, 2017 23411.86
   
Nov. 22, 2017 23228.96
Nov. 21, 2017 23533.80
Nov. 20, 2017 22924.12
Nov. 17, 2017 22741.21
Nov. 16, 2017 22558.31
Nov. 15, 2017 21521.84
Nov. 14, 2017 21765.72
Nov. 13, 2017 21217.00
Nov. 10, 2017 21156.03
Nov. 9, 2017 20851.19
Nov. 8, 2017 20729.25
Nov. 7, 2017 20424.41
Nov. 6, 2017 21156.03
Nov. 3, 2017 21460.88
Nov. 2, 2017 21156.03
Nov. 1, 2017 20912.16
Oct. 31, 2017 21704.75
Oct. 30, 2017 22070.56
Oct. 27, 2017 22497.34
Oct. 26, 2017 22680.24
Oct. 25, 2017 23046.05
Oct. 24, 2017 23350.90
Oct. 23, 2017 23289.93
Oct. 20, 2017 23594.77
Oct. 19, 2017 23533.80

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

NYMX Price to Book Value Benchmarks

Benchmarks
HTG Molecular Diagnostics --
ZIOPHARM Oncology --
Onconova Therapeutics --

NYMX Price to Book Value Range, Past 5 Years

Minimum 20058.60 Dec 27 2017
Maximum 24753.17 Oct 12 2017
Average 22233.14

NYMX Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("NYMX", "price_to_book_value")
  • Last 5 data points: =YCS("NYMX", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.